SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-136565
Filing Date
2023-05-05
Accepted
2023-05-05 07:22:55
Documents
5
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 6-K d322505d6k.htm 6-K 9613
2 EX-99.1 d322505dex991.htm EX-99.1 26055
3 GRAPHIC g322505g0504022734064.jpg GRAPHIC 2861
4 GRAPHIC g322505g0504022734302.jpg GRAPHIC 3586
5 GRAPHIC g322505g18y01.jpg GRAPHIC 759
  Complete submission text file 0001193125-23-136565.txt   47243
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 23891226
SIC: 2834 Pharmaceutical Preparations